1 year ago
Exploring Tumor Vitality: Chinese CAR-T Therapy Grants Patients Complete Remission “Is it true? It’s so unbelievable!” said Chen, the “fortunate one.” O...
1 year ago
“Two Years of Complete Remission, CAR-T therapy has given her a new lease on life. She Thought the Journey Was Over” Yun is a 78-year-old patient who achieved a continuous comp...
1 year ago
Breakthrough Advances in CAR-T Cell Therapy Combined with TKI for Malignant Hematologic System Tumors At this year’s ASH conference, Professor Huang He, the director of the First Affi...
1 year ago
Chinese Research Team New Treatment Shows Promise: CD7 CAR-T Cell Therapy for Relapsed/Refractory AML A recent clinical trial has unveiled a new prospect for treating relapsed/refractory acu...
1 year ago
New Generation CAR-T Cell Therapy AT101: Phase I Clinical Trial Shows 100% Complete Remission Rate! Researchers recently released exciting news: the Phase I clinical trial of their newly dev...
1 year ago
A Chinese research team has made significant advancements in the treatment of colorectal cancer, paving the way for a new milestone in the field of oncology treatment In recent years, natural kill...
2 years ago
Diffuse Large B-cell Lymphoma （LBCL）is a heterogeneous malignant tumor of the blood system, with approximately 40% of LBCL patients experiencing relapse or developing resistance after first-line...
2 years ago
Recently, Professor Huang Huiqiang’s team at Sun Yat-sen University Affiliated Cancer Hospital achieved significant progress in a lymphoma patient who relapsed after five lines of chemotherap...
2 years ago
Chinese pharmaceutical company SciCoMed announced a significant breakthrough in treating metastatic pancreatic cancer with its independently developed CAR-T cell therapy targeting Claudin18.2, kn...
2 years ago
China make advanced medical treatment affordable Wang Fang (pseudonym), residing in Yichang, Hubei, China, underwent a life-threatening ordeal. This patient in her forties had been sufferin...
2 years ago
2020, over 19.3 million people were diagnosed with cancer worldwide, leading to almost 10 million fatalities. In China alone, the number of new cancer patients reached a staggering 4.57 million, ac...
2 years ago
The fifth-generation CAR-T is designed as a universal type of CAR-T. Is this risk-free CAR-T capable of achieving significant breakthroughs in solid tumor treatment, or is it effectively reducing ...
By using our site, you agree to our Terms and Conditions and Privacy Policy.Advanced Medicine In China does not provide medical advice, diagnosis, or treatment. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.
© Copyright 2023 Advanced Medicine In China. All rights reserved.
